Journal of Clinical Oncology, Vol 12, 1484-1490, Copyright © 1994 by American Society of Clinical Oncology
Prognostic factors and outcome of incompletely resected invasive thymoma following radiation therapy
IF Ciernik, U Meier and UM Lutolf
Department of Radiology, University Hospital, Zurich, Switzerland.
BACKGROUND: Stage III and stage IV thymomas with significant macroscopic
infiltration to the neighboring structures are rarely completely
resectable. It therefore remains unclear to what extent tumors must be
surgically debulked to improve prognosis. PATIENTS AND METHODS: We reviewed
the cases of 31 patients with incompletely resected invasive thymoma and
residual macroscopic disease who were referred to postoperative
irradiation. Survival and local tumor control were analyzed. All patients
were treated between 1958 and 1990 with megavoltage irradiation at doses
ranging from 42 to 66 Gy. The shortest follow-up time for living patients
was more than 5 years. RESULTS: The overall median 5-year survival rate was
45%. Eighteen stage III patients had a 5-year survival rate of 61% and a
10-year survival rate of 57%. Thirteen patients had stage IV disease and 5-
and 10-year survival rates of 23% and 8%, respectively. Univariate and
multivariate analyses confirmed a worse prognosis for stage IV disease.
Epithelial or spindle-cell thymoma was associated with stage IV disease.
Twenty- two percent of patients with stage III disease had epithelial or
spindle-cell thymoma, versus 69% of patients with stage IV disease (P = .02
for univariate and P = .05 for multivariate analysis). Initial tumor
diameter greater than 10 cm correlated with poor prognosis in the
univariate analysis (P = .05). However, more importantly, debulking of
tumor did not significantly improve outcome when compared with patients who
received biopsy only. The median survival rate of patients with stage IVa
disease did not differ from that of those with stage IVb disease.
Mediastinal control was achieved in 23 patients (74%). Stage IV disease did
not correlate with an increase in local treatment failure after
irradiation, although epithelial or spindle-cell thymoma predisposed for
local treatment failure (46% v 11%; P = .04 in univariate and P = .055 in
multivariate analysis). CONCLUSION: Tumor debulking leaving macroscopic
residual thymoma, as opposed to biopsy alone, does not improve prognosis
when followed by radiation. Radiation therapy for local tumor control is
most effective in nonepithelial- predominant thymomas.

CiteULike Complore Connotea Del.icio.us Digg Facebook Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
V. VASSILIOU, A. TSAMANDAS, N. KATODRITIS, N. CHAROULIS, A. KOUKOUMA, D. ANDREOPOULOS, S. SALAKOU, V. ZOLOTA, P. PAPATHANASSOPOULOS, G. CHRISTODOULIDES, et al.
The Role of Postoperative Radiotherapy in the Management of Patients with Thymic Tumors -- A Retrospective Study
In Vivo,
September 1, 2009;
23(5):
843 - 852.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Wright, P. Fidias, N. C.H. Choi, J.-A. O. Shepard, and R. P. Hasserjian
Case 16-2007 -- A 61-Year-Old Man with a Mediastinal Mass
N. Engl. J. Med.,
May 24, 2007;
356(21):
2185 - 2193.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. F. Riedel and W. R. Burfeind Jr
Thymoma: Benign Appearance, Malignant Potential
Oncologist,
September 1, 2006;
11(8):
887 - 894.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. C. Detterbeck and A. M. Parsons
Thymic tumors
Ann. Thorac. Surg.,
May 1, 2004;
77(5):
1860 - 1869.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. B. Johnson, T. Y. Eng, G. Giaccone, and C. R. Thomas Jr.
Thymoma: Update for the New Millenium
Oncologist,
June 1, 2001;
6(3):
239 - 246.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Thomas, C. D. Wright, and P. J. Loehrer
Thymoma: State of the Art
J. Clin. Oncol.,
July 1, 1999;
17(7):
2280 - 2280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Bacha, A. R. Chapelier, P. Macchiarini, E. Fadel, and P. G. Dartevelle
Surgery for invasive primary mediastinal tumors
Ann. Thorac. Surg.,
July 1, 1998;
66(1):
234 - 239.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fujino, N. Tezuka, S. Watarida, K. Katsuyama, S. Inoue, and A. Mori
Reconstruction of the aortic arch in invasive thymoma under retrograde cerebral perfusion
Ann. Thorac. Surg.,
July 1, 1998;
66(1):
263 - 264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Yagi, T. Hirata, T. Fukuse, H. Yokomise, K. Inui, O. Ike, H. Mizuno, M. Aoki, S. Hitomi, and H. Wada
Surgical Treatment for Invasive Thymoma, Especially When the Superior Vena Cava Is Invaded
Ann. Thorac. Surg.,
February 1, 1996;
61(2):
521 - 524.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. Blumberg, J. L. Port, B. Weksler, R. Delgado, J. Rosai, M. S. Bains, R. J. Ginsberg, N. Martini, P. M. McCormack, V. Rusch, et al.
Thymoma: A Multivariate Analysis of Factors Predicting Survival
Ann. Thorac. Surg.,
October 1, 1995;
60(4):
908 - 913.
[Abstract]
[Full Text]
|
 |
|
|